Clinical Trials Browser

Small Cell Lung Cancer Extensive Stage × tislelizumab × 1 year × Clear all

NCT06030258 2025-04-30

IN10018 Combination Therapy in Treatment-naïve ES-SCLC

Phase 1/2 Recruiting

Small Cell Lung Cancer Extensive Stage